These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21881536)

  • 41. Heparin-mediated inhibition of PCR in the accelerated phase of chronic myeloid leukaemia characterised by abundant basophilia.
    Satoh Y; Masuda A; Jona M; Nannya Y; Yokota H; Kurokawa M; Yatomi Y
    Eur J Haematol; 2014; 92(5):456-7. PubMed ID: 24373003
    [No Abstract]   [Full Text] [Related]  

  • 42. Diagnosis of minimal residual disease in bone marrow transplant patients.
    Gehly GB
    Clin Lab Med; 1992 Mar; 12(1):129-51. PubMed ID: 1563238
    [No Abstract]   [Full Text] [Related]  

  • 43. Evaluation of Xpert
    Dominy KM; Simon IM; Sorouri-Khorashad J
    Int J Lab Hematol; 2021 Feb; 43(1):e31-e34. PubMed ID: 32990400
    [No Abstract]   [Full Text] [Related]  

  • 44. The benefit of quality control charts (QCC) for routine quantitative BCR-ABL1 monitoring in chronic myeloid leukemia.
    Spiess B; Naumann N; Galuschek N; Rinaldetti S; Kossak-Roth U; Tarnopolscaia I; Felde E; Fabarius A; Hofmann WK; Saußele S; Seifarth W
    PLoS One; 2018; 13(4):e0196326. PubMed ID: 29689094
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Duplex quantitative PCR for molecular monitoring of BCR-ABL1-associated hematological malignancies.
    Gerrard G; Mudge K; Stewart R; Foskett P; Stevens D; Khorashad JS; Szydlo R; Rezvani K; Marin D; Reid A; Apperley J; Goldman J; Foroni L
    Am J Hematol; 2011 Mar; 86(3):313-5. PubMed ID: 21328433
    [No Abstract]   [Full Text] [Related]  

  • 46. Should polymerase chain reaction analysis to detect minimal residual disease in patients with chronic myelogenous leukemia be used in clinical decision making?
    Faderl S; Talpaz M; Kantarjian HM; Estrov Z
    Blood; 1999 May; 93(9):2755-9. PubMed ID: 10216068
    [No Abstract]   [Full Text] [Related]  

  • 47. Minimal residual disease detection in acute lymphoblastic leukemia: real improvement with the real-time quantitative PCR method?
    Neale GA; Campana D; Pui CH
    J Pediatr Hematol Oncol; 2003 Feb; 25(2):100-2. PubMed ID: 12571458
    [No Abstract]   [Full Text] [Related]  

  • 48. Use of Droplet Digital Polymerase Chain Reaction for Detecting Minimal Residual Disease: A Prospective Multi-Institutional Study.
    Park H; Shin DY; Kim I; Sohn SK; Koh Y; Lee JH; Lee KH; Kim DY; Kim HJ; Ahn JS; Lee JO; Bang SM; Cheong JW; Park SG; Park S; Lee YJ; Ahn SY
    In Vivo; 2019; 33(6):2273-2280. PubMed ID: 31662567
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantitative monitoring of the PRAME gene for the detection of minimal residual disease in leukaemia.
    Matsushita M; Ikeda H; Kizaki M; Okamoto S; Ogasawara M; Ikeda Y; Kawakami Y
    Br J Haematol; 2001 Mar; 112(4):916-26. PubMed ID: 11298586
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Minimal residual disease: the advantages of digital over analog polymerase chain reaction.
    Ross DM; Branford S
    Leuk Lymphoma; 2011 Jul; 52(7):1161-3. PubMed ID: 21612381
    [No Abstract]   [Full Text] [Related]  

  • 51. Digital droplet PCR for T315I BCR::ABL1 KD mutation assessment in adult Ph-positive acute lymphoblastic leukemia with a minimal residual disease increase.
    Cardinali D; Beldinanzi M; Ansuinelli M; Elia L; Della Starza I; Bellomarino V; Matarazzo M; Di Trani M; Cola M; Salutari P; Cedrone M; Bassan R; De Gobbi M; Della Porta MG; De Simone M; Alati C; Fracchiolla NS; Lunghi M; Intermesoli T; Cardinali V; Mulè A; Guarini A; Foà R; Chiaretti S
    Leuk Lymphoma; 2023; 64(11):1884-1887. PubMed ID: 37452789
    [No Abstract]   [Full Text] [Related]  

  • 52. The clinical application of molecular techniques in Philadelphia-positive leukaemia.
    Morgan GJ; Wiedemann LM
    Br J Haematol; 1992 Jan; 80(1):1-5. PubMed ID: 1536795
    [No Abstract]   [Full Text] [Related]  

  • 53. Clinical applications of molecular haematology: an overview.
    Bain BJ
    J Assoc Physicians India; 2007 Jul; 55():503-6. PubMed ID: 17907501
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential stability of control gene and fusion gene transcripts over time may hamper accurate quantification of minimal residual disease--a study within the Europe Against Cancer Program.
    van der Velden VH; Boeckx N; Gonzalez M; Malec M; Barbany G; Lion T; Gottardi E; Pallisgaard N; Beillard E; Hop WC; Hoogeveen PG; Gabert J; van Dongen JJ;
    Leukemia; 2004 Apr; 18(4):884-6. PubMed ID: 14961029
    [No Abstract]   [Full Text] [Related]  

  • 55. Polymerase chain reaction analyses should be used as a basis for clinical decision making in patients with chronic myelogenous leukemia.
    Moravcová J; Nádvorníková S; Lukásová M; Klamová H
    Blood; 1999 Nov; 94(10):3609-11. PubMed ID: 10610116
    [No Abstract]   [Full Text] [Related]  

  • 56. Molecular oncology: current trends in diagnostics.
    Lefferts JA; Bartels CL; Tsongalis GJ
    Future Oncol; 2008 Feb; 4(1):61-70. PubMed ID: 18241001
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Study on hypermethylation of the calcitonin gene in malignant hematological disorders].
    Tang Y; Deng C; Du Q; Li G
    Hua Xi Yi Ke Da Xue Xue Bao; 2001 Mar; 32(1):86-8. PubMed ID: 12733364
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Haematological malignancies in developing countries: is CML the commonest childhood leukaemia?
    Wechalekar AD; Parande CM
    Leukemia; 2007 Oct; 21(10):2194; author reply 2195. PubMed ID: 17673905
    [No Abstract]   [Full Text] [Related]  

  • 59. [Leukemia].
    Schalhorn A
    MMW Fortschr Med; 2013 Nov; 155(19):48-52; quiz 53. PubMed ID: 24475671
    [No Abstract]   [Full Text] [Related]  

  • 60. Next-generation sequencing for measurable residual disease detection in acute myeloid leukaemia.
    Ghannam J; Dillon LW; Hourigan CS
    Br J Haematol; 2020 Jan; 188(1):77-85. PubMed ID: 31804716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.